Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Aolidanide Pharmaceutical, a key subsidiary of the Heilongjiang Aolida Pharmaceutical Group, is a prominent Chinese pharmaceutical manufacturer based in Qing'an County. The company specializes in a diverse range of products, including chemical drugs and traditional Chinese patent medicines, with a particular focus on cardiovascular, respiratory, and metabolic health. It leverages a proprietary sustained-release pellet technology platform to develop high-quality formulations such as Allopurinol sustained-release capsules and Niuhuang Qinggan Capsules. With GMP-certified facilities, the company produces various dosage forms including tablets, capsules, and injections, serving both domestic and international markets. Heilongjiang Aolidanide is recognized as a high-tech enterprise and plays a significant role in the regional pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Aolidanide Pharmaceutical.